DuPont (NYSE:DD) delivered better-than-expected fourth-quarter earnings, fueled by robust demand in electronics and resurgent growth in water and healthcare markets. The upbeat results, coupled with an optimistic 2025 forecast, sent the stock up 8% intra-day today.
For Q4, the chemical giant reported adjusted earnings per share of $1.13, surpassing analyst expectations of $0.99. Revenue came in at $3.09 billion, slightly above estimates of $3.08 billion, reflecting a 7% year-over-year increase in both net and organic sales.
The strong performance was driven by an 8% volume increase, particularly in electronics markets, while a 1% price decline provided a slight offset. Healthcare saw renewed strength in medical packaging and biopharma, while water market growth accelerated, signaling broad-based recovery across key sectors.
Looking ahead, DuPont provided an optimistic outlook for 2025. The company expects Q1 earnings per share of $0.95, slightly ahead of analyst forecasts of $0.93, with revenue projected at $3.025 billion. Full-year 2025 guidance includes EPS between $4.30 and $4.40 and revenue in the range of $12.8 billion to $12.9 billion.